MYC.md
... ...
@@ -2,6 +2,8 @@
2 2
bibliography: 'morinlab.bib'
3 3
csl: 'NLM.csl'
4 4
link-citations: true
5
+nocite: |
6
+ @dunsCharacterizationDLBCLPMBL2021, @jalladesExomeSequencingIdentifies2017, @johnstonCmycHypermutationBurkitt1992, @pasqualucciHypermutationMultipleProtooncogenes2001
5 7
---
6 8
[[_TOC_]]
7 9
... ...
@@ -11,13 +13,7 @@ MYC is one of [a number of genes](https://github.com/morinlab/LLMPP/wiki/ashm) a
11 13
12 14
## Relevance tier by entity
13 15
14
-|Entity|Tier|Description |
15
-|:------:|:----:|--------------------------------------|
16
-|![PMBL](images/icons/PMBL_tier2.png)|2|relevance in PMBL/cHL/GZL not firmly established[@dunsCharacterizationDLBCLPMBL2021]|
17
-|![MZL](images/icons/MZL_tier2.png)|2|relevance in MZL not firmly established[@jalladesExomeSequencingIdentifies2017]|
18
-|![BL](images/icons/BL_tier1.png) |1 | aSHM target and high-confidence BL gene [@johnstonCmycHypermutationBurkitt1992]|
19
-|![DLBCL](images/icons/DLBCL_tier1.png) |1 | aSHM target and high-confidence DLBCL gene [@pasqualucciHypermutationMultipleProtooncogenes2001]|
20
-|![FL](images/icons/FL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in FL is tenuous |
16
+[[include:table1_MYC]]
21 17
22 18
## Mutation incidence in large patient cohorts (GAMBL reanalysis)
23 19